Topic

Pennsylvania

A collection of 444 issues

How to Get Vanflyta (quizartinib) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Vanflyta Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Vanflyta (quizartinib) through OptumRx, with specific criteria including confirmed FLT3-ITD mutation, baseline EKG showing QTc ≤450ms, and use in newly diagnosed AML. Submit via the OptumRx provider portal with complete documentation. If denied, Pennsylvania's
5 min read

How to Get Cometriq (Cabozantinib) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cometriq Covered by Cigna in Pennsylvania Cigna covers Cometriq (cabozantinib capsules) for metastatic medullary thyroid carcinoma with prior authorization. Your oncologist submits a PA request including pathology confirming MTC diagnosis, recent imaging showing progression, and elevated calcitonin/CEA levels. If denied, Pennsylvania's new Independent External
6 min read

How to Get Prolastin-C Approved by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Prolastin-C Approved by UnitedHealthcare in Pennsylvania Prolastin-C requires prior authorization from UnitedHealthcare OptumRx for Pennsylvania patients. To get approved: (1) Gather genetic testing showing Pi*ZZ genotype, recent lung function tests (FEV1), and chest CT showing emphysema, (2) Submit PA via UHCprovider.com portal with ICD-10 codes
6 min read

How to Get Evrysdi (risdiplam) Covered by Blue Cross Blue Shield in Pennsylvania: Complete 2025 Guide with Forms and Appeal Scripts

Answer Box: Your Fastest Path to Evrysdi Coverage To get Evrysdi (risdiplam) covered by Blue Cross Blue Shield in Pennsylvania: Submit a prior authorization with genetic SMA confirmation, baseline motor assessment scores (CHOP INTEND or HFMSE), and weight-based dosing documentation. If denied, use Pennsylvania's Independent External Review program—
5 min read

How Long Does It Take to Get Uplizna (Inebilizumab) Approved by Humana in Pennsylvania? Complete Timeline Guide

Answer Box: Uplizna (Inebilizumab) Approval Timeline with Humana in Pennsylvania Humana Medicare Advantage plans require prior authorization for Uplizna (inebilizumab), typically deciding within 7 days for standard requests or 72 hours for expedited cases. Pennsylvania patients benefit from a state external review process that overturns ~50% of denials. Key requirements:
6 min read